[Hanyu Pharmaceutical: HY3000 Nasal Spray Clinical Trial Registration Application Accepted] Financial Associated Press on August 4, Hanyu Pharmaceutical announced that the HY3000 nasal spray clinical trial registration application was accepted, and this application for clinical trial The indication of the trial is the prevention of novel coronavirus pneumonia.